Terms: = Breast cancer AND NCOR2, SMRTE-tau, 9612, ENSG00000196498, SMRTE, TNRC14, TRAC-1, SMRT, CTG26, TRAC1
101 results:
1. Overexpression of BQ323636.1 contributes to anastrozole resistance in AR+ve/ER+ve breast cancer.
Tsoi H; Lok J; Man EP; Cheng CN; Leung MH; You CP; Chan SY; Chan WL; Khoo US
J Pathol; 2023 Oct; 261(2):156-168. PubMed ID: 37555303
[TBL] [Abstract] [Full Text] [Related]
2. Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα
Poulard C; Ha Pham T; Drouet Y; Jacquemetton J; Surmielova A; Kassem L; Mery B; Lasset C; Reboulet J; Treilleux I; Marangoni E; Trédan O; Le Romancer M
EMBO Mol Med; 2023 Aug; 15(8):e17248. PubMed ID: 37458145
[TBL] [Abstract] [Full Text] [Related]
3. Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive breast cancer.
Tsoi H; Tsang WC; Man EPS; Leung MH; You CP; Chan SY; Chan WL; Khoo US
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293165
[TBL] [Abstract] [Full Text] [Related]
4. Screening of organoids derived from patients with breast cancer implicates the repressor ncor2 in cytotoxic stress response and antitumor immunity.
Tsai KK; Huang SS; Northey JJ; Liao WY; Hsu CC; Cheng LH; Werner ME; Chuu CP; Chatterjee C; Lakins JN; Weaver VM
Nat Cancer; 2022 Jun; 3(6):734-752. PubMed ID: 35618935
[TBL] [Abstract] [Full Text] [Related]
5. Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER
Ma S; Tang T; Probst G; Konradi A; Jin C; Li F; Gutkind JS; Fu XD; Guan KL
Nat Commun; 2022 Feb; 13(1):1061. PubMed ID: 35217640
[TBL] [Abstract] [Full Text] [Related]
6. Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1.
Abascal MF; Elia A; Alvarez M; Pataccini G; Sequeira G; Riggio M; Figueroa V; Lamb CA; Rojas PA; Spengler E; Martínez-Vazquez P; Burruchaga J; Liguori M; Sahores A; Wargon V; Molinolo A; Hewitt S; Lombes M; Sartorius C; Vanzulli SI; Giulianelli S; Lanari C
Int J Cancer; 2022 May; 150(9):1481-1496. PubMed ID: 34935137
[TBL] [Abstract] [Full Text] [Related]
7. Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate.
Zhao J; Sun G; Zhu S; Dai J; Chen J; Zhang M; Ni Y; Zhang H; Shen P; Zhao X; Zhang B; Pan X; Nie L; Yin X; Liang J; Zhang X; Wang Z; Zhu X; Liao B; Liu Z; Armstrong CM; Gao AC; Huang H; Chen N; Zeng H
BJU Int; 2022 Mar; 129(3):345-355. PubMed ID: 34185954
[TBL] [Abstract] [Full Text] [Related]
8. The pan-cancer lncRNA PLANE regulates an alternative splicing program to promote cancer pathogenesis.
Teng L; Feng YC; Guo ST; Wang PL; Qi TF; Yue YM; Wang SX; Zhang SN; Tang CX; La T; Zhang YY; Zhao XH; Gao JN; Wei LY; Zhang D; Wang JY; Shi Y; Liu XY; Li JM; Cao H; Liu T; Thorne RF; Jin L; Shao FM; Zhang XD
Nat Commun; 2021 Jun; 12(1):3734. PubMed ID: 34145290
[TBL] [Abstract] [Full Text] [Related]
9. CUL4B Promotes breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway.
Huang W; Zhang J; Huo M; Gao J; Yang T; Yin X; Wang P; Leng S; Feng D; Chen Y; Yang Y; Wang Y
Adv Sci (Weinh); 2021 May; 8(10):2001515. PubMed ID: 34026424
[TBL] [Abstract] [Full Text] [Related]
10. Nuclear translocation of MRTFA in MCF7 breast cancer cells shifts ERα nuclear/genomic to extra-nuclear/non genomic actions.
Jehanno C; Percevault F; Boujrad N; Le Goff P; Fontaine C; Arnal JF; Primig M; Pakdel F; Michel D; Métivier R; Flouriot G
Mol Cell Endocrinol; 2021 Jun; 530():111282. PubMed ID: 33894309
[TBL] [Abstract] [Full Text] [Related]
11. Acquired mutations and transcriptional remodeling in long-term estrogen-deprived locoregional breast cancer recurrences.
Priedigkeit N; Ding K; Horne W; Kolls JK; Du T; Lucas PC; Blohmer JU; Denkert C; Machleidt A; Ingold-Heppner B; Oesterreich S; Lee AV
Breast Cancer Res; 2021 Jan; 23(1):1. PubMed ID: 33407744
[TBL] [Abstract] [Full Text] [Related]
12. Thyroid Hormones, Silencing Mediator for Retinoid and Thyroid Receptors and Prognosis in Primary breast cancer.
Nisman B; Allweis TM; Carmon E; Kadouri L; Maly B; Maimon O; Meierovich A; Peretz T
Anticancer Res; 2020 Nov; 40(11):6417-6428. PubMed ID: 33109580
[TBL] [Abstract] [Full Text] [Related]
13. Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription.
Zou G; Zhang X; Wang L; Li X; Xie T; Zhao J; Yan J; Wang L; Ye H; Jiao S; Xiang R; Shi Y
Theranostics; 2020; 10(15):6839-6853. PubMed ID: 32550907
[TBL] [Abstract] [Full Text] [Related]
14. ER-Negative breast cancer Is Highly Responsive to Cholesterol Metabolite Signalling.
Hutchinson SA; Lianto P; Roberg-Larsen H; Battaglia S; Hughes TA; Thorne JL
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31683867
[TBL] [Abstract] [Full Text] [Related]
15. Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells.
Zhang X; Zhang B; Zhang P; Lian L; Li L; Qiu Z; Qian K; Chen A; Liu Q; Jiang Y; Cui J; Qi B
PLoS One; 2019; 14(5):e0217181. PubMed ID: 31120927
[TBL] [Abstract] [Full Text] [Related]
16. Obesity impacts the regulation of miR-10b and its targets in primary breast tumors.
Meerson A; Eliraz Y; Yehuda H; Knight B; Crundwell M; Ferguson D; Lee BP; Harries LW
BMC Cancer; 2019 Jan; 19(1):86. PubMed ID: 30658617
[TBL] [Abstract] [Full Text] [Related]
17. Tumor-Specific Mitochondrial DNA Variants Are Rarely Detected in Cell-Free DNA.
Weerts MJA; Timmermans EC; van de Stolpe A; Vossen RHAM; Anvar SY; Foekens JA; Sleijfer S; Martens JWM
Neoplasia; 2018 Jul; 20(7):687-696. PubMed ID: 29842994
[TBL] [Abstract] [Full Text] [Related]
18. Selective nanopore sequencing of human BRCA1 by Cas9-assisted targeting of chromosome segments (CATCH).
Gabrieli T; Sharim H; Fridman D; Arbib N; Michaeli Y; Ebenstein Y
Nucleic Acids Res; 2018 Aug; 46(14):e87. PubMed ID: 29788371
[TBL] [Abstract] [Full Text] [Related]
19. Tamoxifen Resistance Trumped and Oral Selective Estrogen Receptor Degraders Arrive.
Jordan VC
Clin Cancer Res; 2018 Aug; 24(15):3480-3482. PubMed ID: 29674510
[TBL] [Abstract] [Full Text] [Related]
20. BQ323636.1, a Novel Splice Variant to
Gong C; Man EPS; Tsoi H; Lee TKW; Lee P; Ma ST; Wong LS; Luk MY; Rakha EA; Green AR; Ellis IO; Lam EW; Cheung KL; Khoo US
Clin Cancer Res; 2018 Aug; 24(15):3681-3691. PubMed ID: 29420220
[No Abstract] [Full Text] [Related]
[Next]